The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies.
about
Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approachesPlasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrinEffects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.New therapeutic targets for the antiphospholipid syndrome.Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes.Role of tissue factor in thrombosis in antiphospholipid antibody syndrome.Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome.β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.Mass spectrometric characterization of gelsolin isoforms.The Effects of NF-κB and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-β2GPI in MouseAnti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome.Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.Antiphospholipid syndrome and tissue factor: a thrombotic couple.Pathophysiological mechanisms in antiphospholipid syndromeIs there a microangiopathic antiphospholipid syndrome?Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.Tissue factor in the antiphospholipid syndrome.C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodiesAnti-human protein S antibody induces tissue factor expression through a direct interaction with platelet phosphofructokinaseComplement activation and pregnancy failure.Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK.Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.Potential use of statins in the treatment of antiphospholipid syndrome.The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.Biomarkers for cardiovascular risk assessment in autoimmune diseases.Antiphospholipid syndrome: 30 years and our contribution.Platelets express three different splice variants of ApoER2 that are all involved in signaling.How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores.My contribution, my dream - a look at the future of APS.Role of apolipoprotein B100 and oxidized low-density lipoprotein in the monocyte tissue factor induction mediated by anti-β2 glycoprotein I antibodies.Activation of the non-receptor tyrosine kinase cSrc in macrophage-rich atherosclerotic plaques of human carotid arteriesGene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.The involvement of CD36 in monocyte activation by antiphospholipid antibodies.In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies.Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2.Innate immune response gene expression profiles characterize primary antiphospholipid syndrome.Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody.Abdominal pain, flank pain, blurry vision, and lower extremity weakness in a 16-year-old female.
P2860
Q28075691-D62CA642-395B-4564-A9DC-324DCEA0A25FQ33511345-BD597562-5013-4C61-AA8A-CAD9FDCA1210Q33967600-4307A830-5823-4238-A81D-4060D1A27F71Q34140319-EAA5E6FD-089A-40F2-9910-02CC947DCAEAQ34287356-D1AF8E40-5401-4C05-A0B0-DF02526C02C0Q34514845-2794E011-3EB1-4FB5-AFCC-9A766064C0ACQ34676688-849319BB-7B08-4500-A778-2144AAC64288Q34684028-BAC6F694-0BB1-4B24-A43A-590891633642Q35584256-436E1E04-5302-4CC3-86E6-6E2746C1DE40Q35778813-336C0EAD-EE23-4D5E-AAB7-A66BE9A4D532Q35909733-5555F3AA-49D9-4FFF-8575-25C5F6A02DFFQ35953541-FB7B602D-925A-48E5-BEC4-613E022AAAB1Q36287542-E5EFA1D7-C1FD-4390-8ACA-253E1C3F3D43Q36458154-C6BE2B0F-0BCE-49E5-9DDE-51FE78D19F9AQ36671159-0441FA20-AD1A-47BF-906D-7F2A328E5766Q36759849-0B061FEC-7A09-40E0-B9D8-964B5AB5B514Q37283020-55069B6C-3B07-48FD-9D64-B7C6BE98AC21Q37283046-7E93DBB7-A725-46B4-8E41-7368E7C130E1Q37581827-9620F88E-A30D-424A-A778-E98DA2CF8097Q37625870-607723A1-7966-4B86-B03E-840B615FC4D0Q37638376-7E4A0149-6198-4362-9A23-0A920267F2DEQ37721617-E4AE823F-5513-4B35-8715-8438B2B23A00Q37744837-0E65A6D9-723B-4DAE-8653-6CDB989DE4C9Q37903952-655A4FF5-5A04-4273-95DD-1453B75056F5Q37959316-9A860D6B-7583-429C-B098-1040493B3493Q38158240-6BE4C080-07B0-43E2-AB9D-D23A309D27F8Q38293735-A1B67172-3B0C-4EBF-8EA6-BA939AAB4A1BQ38294180-A8941C8C-0060-49C2-98BB-0EB6A19A0661Q38302213-93F53DEF-DFA2-441F-A45A-0E949926C6EEQ38663014-48B124B9-45BC-4B29-AF67-772373D0C9DFQ39127887-7D37452C-1963-4004-A0CD-0C8F8C324C2AQ39931228-1FD49721-D855-444F-A403-C9E35DD49B11Q41760927-6F356FE7-F32F-4425-8F78-0A0C8DBA4F15Q42647843-F1E94384-01D3-4276-91D5-45D7C27D7883Q43713854-4A41AD03-3091-4D74-8FA7-F44F84E8C5E4Q46982839-A52C2CF4-E592-477C-B7ED-E53C34897471Q47698131-43E937A7-DC1E-475E-B780-9EF7D10C5C96Q47743642-5ACF6956-5948-4B18-B9ED-3F3E4A983AAAQ47954105-9163C2C4-9359-45CF-99B7-BD08DD936B61Q51144375-3F6210B4-30E9-4FC8-B51E-523EF7FB9E53
P2860
The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The p38 mitogen-activated prot ...... eta2Glycoprotein I antibodies.
@en
type
label
The p38 mitogen-activated prot ...... eta2Glycoprotein I antibodies.
@en
prefLabel
The p38 mitogen-activated prot ...... eta2Glycoprotein I antibodies.
@en
P2093
P356
P1476
The p38 mitogen-activated prot ...... eta2Glycoprotein I antibodies.
@en
P2093
Akira Furusaki
Miyuki Bohgaki
Olga Amengual
Shinsuke Yasuda
Tatsuya Atsumi
Toshiyuki Bohgaki
Yoshie Sakai
Yoshiharu Amasaki
Yumi Yamashita
P304
P356
10.1093/INTIMM/DXH166
P50
P577
2004-10-05T00:00:00Z